@article{HBSN20899,
author = {Mathilde Wisniewski and Pierre-Alain Placide and Sandra Granier and Yacoub Al Shatti and Shuaib Al Qalaf and Mohamed Bouattour and Michele Lamuraglia and Pascal Hammel},
title = {Adjuvant chemotherapy with gemcitabine plus erlotinib vs. gemcitabine alone for patients with resected pancreatic ductal adenocarcinoma: is there a role for erlotinib?—review of the open label phase III trial CONKO 005},
journal = {Hepatobiliary Surgery and Nutrition},
volume = {7},
number = {5},
year = {2018},
keywords = {},
abstract = {Sinn et al. (1) report the results of a multicenter trial comparing the combination of gemcitabine and erlotinib with gemcitabine alone for adjuvant therapy in 436 patients who underwent R0 resection for pancreatic ductal carcinoma (PDAC).},
issn = {2304-389X}, url = {https://hbsn.amegroups.org/article/view/20899}
}